Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Valero Energy Corporation (VLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Valero Energy Corporation — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Valero Energy Corporation trades at $433.75 (market cap $127.78B). The key difference: Valero Energy Corporation is far larger — about 10.2× Halozyme Therapeutics Inc. Common Stock's market cap, and Valero Energy Corporation pays a 1.08% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Valero Energy Corporation for 56 Days on average.
| HALO | VLO | |
|---|---|---|
Market Cap | $12.58B | $127.78B |
Volume | 2,179,278 | 2,570,225 |
Sector | Health | Energy |
52-Week High | $115.22 | $443.80 |
52-Week Low | $61.63 | $156.39 |
Typical Hold Time | 1 Days | 56 Days |
Enterprise Value | $14.49B | $131.26B |
Dividend Yield | — | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Valero Energy (VLO) trades at $443.8, up 4.65% today, near its 52-week high. The stock shows strong technical momentum with bullish moving averages, though RSI levels indicate overbought conditions. Fundamentally, VLO has beaten earnings estimates for three consecutive quarters, with Q3 2026 expected at $20.17 EPS. Revenue has declined from $176.4B in 2022 to $122.7B in 2025, but net income margin improved to 5.17% in 2026 projections. Analyst sentiment is predominantly positive with 54% buy ratings.
VLO's outlook is supported by refining margin strength and a solid balance sheet, but risks include potential diesel export bans and volatile energy markets. The consensus price target is $408.10, below the current price, suggesting limited near-term upside. Investors should weigh strong operational performance against macroeconomic and policy uncertainties in the energy sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →
